Mono- and biphasic plasma concentration-time curves of mesalazine from a 500 mg suppository in healthy male volunteers controlled by the time of defecation before dosing

Journal of Pharmacy and Pharmacology

Volumn 52, Issue 6, 2000, Pages 645-652

  Vree, Tom B ^d   Dammers, Erik ^a   Exler, Peter S ^b   Maes, Robert A A ^c  

^a DADA Consultancy   (Netherlands)

^b Disphar International   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

5 ACETAMIDOSALICYLIC ACID; MESALAZINE;

ARTICLE; BIOEQUIVALENCE; DEFECATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG RELEASE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; RECTUM; SUPPOSITORY;

EID: 0034047047     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357001774471     Document Type: Article

References (16)

1. Ahnfelt-Rønne, I., Nielsen, O. H., Christensen, A., Langholz, E., Binder, V., Riis, P. (1990) Clinical evidence supporting the radical scavenger mechanism of 5-aminosalicylic acid. Gastroenterology 98: 1162-1169
2. Bondesen, S., Hegnhoj, J., Larsen, F., Hansen, S. H., Rasmussen, S. N. (1991) Pharmacokinetics of mesalazine in man following administration of intravenous bolus and per os slow-release formulation. Dig. Dis. Sci. 36: 1735-1740
3. Brogden, R. N., Sorkin, E. M. (1989) Mesalazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in chronic inflammatory bowel disease. Drugs 38: 500-523
4. Christensen, L. A., Slot, O., Sanchez, G., Boserup, J., Rasmussen, S. N., Bondesen, S., Hansen, S. H., Hvidberg, E. F. (1987) Release of mesalazine from Pentasa during normal and accelerated intestinal transit time. Br. J. Clin. Pharmacol. 23: 365-369
5. Fischer, C., Maier, K., Stumpf, E., von Garsberg, U., Klotz, U. (1983) Disposition of 5-aminosalicylic acid, the active metabolite of sulphasalazine in man. Eur. J. Clin. Pharmacol. 25: 511-515
6. Hardy, J. G., Healey, J. N. C., Reynolds, J. R. (1987) Evaluation of an enteric-coated delayed-release mesalazine tablet in patients with inflammatory bowel disease. Aliment. Pharmacol. Ther. 1: 273-280
7. Heinzel, R., Woloszczak, R., Thomann, P. (1993) Topfit 2.0. Pharmacokinetic and Pharmacodynamic Data Analysis System for the PC. New York
8. Jacobsen, B. A., Abildgaard, K., Rasmussen, H. H., Christensen, L. A., Fallingborg, J., Hansen, S. H., Rasmussen, S. N. (1991) Availability of mesalazine from enemas and suppositories during steady stale conditions. Scand. J. Gastroenterol. 26: 374-378
9. Jensen, J., Cornett, C., Olsen, C. E., Bondesen, S., Christensen, J., Christensen, L. A., TjørnElund, J., Hansen, S. H. (1993) Indentification of oxidation products of mesalazine in faeces and the study of their formation in vitro. Biochem. Pharmacol. 45: 1201-1209
10. Martindale (1996) Gastro-intestinal agents. Mesalazine. In: Reynolds, J. E. F. (ed.) The Extra Pharmacopoeia. 31st edn, Pharmaceutical Press, London, pp 1227-1228
11. Meyers, B., Evans, D. N. W., Rhodes, J., Evans, B. K., Hughes, B. R. (1987) Metabolism and urinary excretion of mesalazine in healthy volunteers given intravenously or released for absorption at different sites in the gastro-intestinal tract. Gut 28: 196-200
12. Norlander, B., Gotthard, R., Ström, M. (1989) Pharmacokinetics of a mesalazine enteric coated tablet and suppository dosage form. Aliment. Pharmacol. Ther. 3: 333-342
13. Prakash, A., Markham, A. (1999) Oral delayed-release mesalazine. A review of its use in ulcerative colitis and Crohn's disease. Drugs 57: 383-408
14. Riley, S. A., Tavares, I. A., Bishai, P. M., Bennett, A., Mani, V. (1991) Mesalazine release from coated tablets: effect of dietary fibre. Br. J. Clin. Pharmacol. 32: 248-250
15. Wiltink, E. H. H., Mulder, C. J. J., Stolk, L. M. L., Rietbroek, R., Verbeek, C., Tytgat, G. N. J. (1990) Absorption of oral mesalazine containing formulations and the influence of famotidine on the absorption. Scand. J. Gastroenterol. 25: 579-584
16. Yu, D. K., Morrill, B., Eichmeier, L. S., Lanman, R. C., Lanmun, M. B., Giesing, D. H., Weir, S. J. (1995) Pharmacokinetics of mesalazine from controlled-release capsules in man. Eur. J. Clin. Pharmacol. 48: 273-277